Clinical Trial Results:
A 4-week, multicentre, randomized, double-blind, double-dummy, parallel group ambulatory blood pressure monitoring study to demonstrate that treatment with lumiracoxib 100 mg o.d. results in an improved 24-hour blood pressure profile compared to ibuprofen 600 mg t.i.d. in OA patients with controlled hypertension
Summary
|
|
EudraCT number |
2005-003286-17 |
Trial protocol |
DE AT SE GB FI |
Global completion date |
29 Sep 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
31 May 2017
|
First version publication date |
06 Jan 2017
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
2005-003286-17 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.